Roche in the news
Roche in the news

Catch up on the latest news, innovation and thought leadership from Roche Diagnostics.

Clinical Lab Products Magazine

June 18, 2025

Should labs add Lp(a) testing to their menus?

Alexander Fohl, scientific partner for cardiometabolism, explores why labs should consider adding Lp(a) testing to their menus. Discover how this crucial biomarker improves cardiovascular risk assessment, its clinical utility, and the benefits of standardization for broader adoption. Learn more about elevating patient care.

Read more

American Journal of Clinical Pathology

June 10, 2025

Roche Digital Pathology Dx whole slide imaging system is comparable to traditional microscopy for primary diagnosis in surgical pathology

A new study in AJCP highlights the robust evaluation of the Roche Digital Pathology Dx system. This research demonstrates its strong precision and accuracy, proving comparability to traditional microscopy for primary diagnosis in surgical pathology.

Read more

Becker Hospital Review

May 28, 2025

Sanford Health rolls out automated system

Sanford Health is the first U.S. health system to adopt Molecular Process Optimization, an intelligent automation technology developed by Roche Diagnostics. This new solution streamlines molecular testing to boost efficiency, cut turnaround times, and reduce costs.

Read more

Neurology Today

March 25, 2025

Streamlining patient pathways in Alzheimer's disease with emerging biomarkers

Dr. Maria-Magdalena Patru highlights how blood-based biomarkers are transforming early Alzheimer’s detection – offering scalable, minimally invasive testing to support timely diagnoses and improve patient care pathways.

Read more

Clinical Lab Products Magazine

March 25, 2025

COVID next: Charting an evolving industry

Clinical diagnostics is evolving rapidly in the wake of COVID-19. Industry leaders highlight trends like AI, automation and at-home testing that show how clinical diagnostics are evolving after COVID-19’s pandemic phase.

Read more

Clinical Lab Products Magazine

March 24, 2025

The COVID-19 pandemic: Five years on

Nathan Patton, vice president of Near Patient Care marketing, joins industry experts to reflect on COVID-19’s impact – from early challenges to the rise of point-of-care testing and stronger public health preparedness.

Read more

Infectious Diseases Today - Contagion Live

March 20, 2025

The COVID-19 pandemic: Significance of screening and industry's response

The pandemic reshaped public attitudes toward self-care and diagnostics. Nathan Patton, vice president of near patient care marketing, shares how expanded testing access and collaboration are shaping future public health efforts.

Read more

CAP Today

May 3, 2024

Digital pathology mini-roundtable

Is digital pathology on the move? Two who know it well say it is. Esther Abels, a precision medicine and biomedical regulatory health science expert who is CEO of SolarisRTC and former president of the Digital Pathology Association, and Michael Rivers, vice president/lifecycle leader of digital pathology at Roche Tissue Diagnostics, spoke in September with CAP TODAY publisher Bob McGonnagle, who got their take on where things stand.

Read more

Medical Laboratory Observer

April 22, 2024

2024 lab management best practices trend back to the basics

The results of the 2024 Medical Laboratory Observer (MLO) State of the Industry (SOI) Survey on Lab Management Best Practices reveal how many lab professionals are turning to fundamental practices and priorities to make operational, clinical and financial improvements – from a focus on staff career development to strengthening supplier relationships.

Read more

MedTech Dive

April 12, 2024

Roche scores FDA breakthrough status for Alzheimer’s blood test

Roche has received the Food and Drug Administration’s breakthrough device designation for a blood test to support earlier diagnosis of Alzheimer’s disease, the Swiss drug and diagnostics company said Thursday. The test, once approved, could help healthcare providers identify whether amyloid pathology, a marker for Alzheimer’s disease, is present or absent in patients. The Elecsys pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly.

Read more

Contemporary OBGYN

April 3, 2024

Enhancing cervical cancer management with dual stain

In a video interview, Carolyn Kay, MD, discusses the latest ASCCP guidelines and the introduction of dual stain cytology for improved HPV detection and patient management, aiming to alleviate anxiety and enhance efficacy in cervical cancer prevention.

Read more

Medical Laboratory Observer

February 26, 2024

Diabetes and heart failure: Understanding the role of cardiac biomarker testing

Laboratories may begin to see an influx of cardiac biomarker tests accompanying HbA1c testing based on updated American Diabetes Association guidelines concerning heart failure in people with diabetes.

Read more

Medical Laboratory Observer

February 26, 2024

Closing clinical gaps in cervical cancer

In the past 40 years, the number of cases and deaths from cervical cancer have decreased significantly as more women regularly had Pap tests and with the introduction of human papillomavirus (HPV) testing and the development of HPV vaccines.

Read more

Medical Laboratory Observer

November 20, 2023

Actionable answers: Targeted multiplex PCR respiratory testing at the point of care

In the unpredictable post-COVID-19 pandemic era, patient expectations have shifted when it comes to diagnostic testing.

Read more

CLP

November 16, 2023

16 clinical laboratory predictions for 2024

Consolidation, legislation, new testing modalities, and a shift to more consumer-driven testing are just some of the clinical laboratory predictions for 2024.

Read more

Medscape

November 15, 2023

Blood test for MS activity gets FDA breakthrough designation

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Elecsys Neurofilament Light Chain (NfL) test for multiple sclerosis (MS). Made by Roche, the test is intended to be used as an aid in detection of disease activity in adults aged 18-55 years with relapsing-remitting multiple sclerosis (RRMS) or secondary progressive multiple sclerosis (SPMS), providing insights for disease management.

Read more

CLP

October 17, 2023

Roche launches automated vertical transportation for patient lab samples

Roche has launched a laboratory conveyor system, the cobas connection modules (CCM) Vertical, for the U.S. market. The elevator and overhead components of its fully automated and modular CCM system are designed to help low-, mid-, and high-volume laboratories optimize space, productivity, and patient care.

Read more

NeurologyLive

June 27, 2023

FDA clears Roche’s Beta-Amyloid and Total-Tau assays for Alzheimer assessment

With the approval, Roche has three FDA-cleared tests that are reflective of the main Alzheimer's disease pathologies and help clinicians more completely define the disease biologically.

Read more

Medical Laboratory Observer

January 23, 2023

Shifting HIV focus from at-risk populations to at-risk behavior

Since 2015, only about 1.2 million people have been considered ‘at risk’ of HIV and potentially able to benefit from pre-exposure prophylaxis, also known as PrEP, according to medical literature. These numbers were gleaned by focusing on identifiable populations, such as men who have sex with men and drug users who use needles.

Read more

Medical Laboratory Observer

September 21, 2022

Breast cancer biomarkers, and a new clinical category for HER2 expression

Recent advances in treating breast cancer are reaching back to the past to the first known biomarker, human epidermal growth factor, to determine its value in treating patients with lower levels of HER2 expression and potentially open the door to new, targeted, and personalized therapies for many patients.

Read more

Medical Laboratory Observer

August 24, 2022

Navigating respiratory disease testing challenges this fall

If respiratory diseases were not complicated enough before COVID-19, this fall may be the example of peak complexity as atypical infectious disease seasons threaten to become the new normal and COVID-19 continues to mutate.

Read more